Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Intensive care medicine

Lungpacer Medical
Business

Lungpacer Study Projects $24,000 Savings Per AeroPace Case

August 4, 2026August 2, 2026 - by Timothy Alexander

EXTON, PA — Lungpacer Medical said a new economic analysis projects its AeroPace diaphragm-stimulation system could reduce hospital and post-acute care costs by about $24,000 per patient before device expenses, …

Lungpacer Study Projects $24,000 Savings Per AeroPace Case Read More

Lungpacer Medical
Business

Lungpacer Gains CPT Codes to Advance AeroPace Reimbursement

July 30, 2026July 30, 2026 - by Timothy Alexander

EXTON, PA — Lungpacer Medical secured three new medical billing codes for its AeroPace diaphragm neurostimulation system effective July 1, advancing the company’s effort to establish broader reimbursement for hospitals …

Lungpacer Gains CPT Codes to Advance AeroPace Reimbursement Read More
Lungpacer Medical
Health / Medical

ICU Breakthrough: First Patients Breathe Free With Lungpacer’s AeroPace

December 16, 2025December 15, 2025 - by Timothy Alexander

EXTON, PA — Lungpacer Medical says physicians at one of the nation’s largest healthcare systems have completed the first commercial procedures using its FDA-approved AeroPace System, marking a pivotal step …

ICU Breakthrough: First Patients Breathe Free With Lungpacer’s AeroPace Read More

Lungpacer Medical
Research

Lungpacer Medical Publishes Landmark Findings on AeroPace System in Critical Care

June 13, 2025June 12, 2025 - by Timothy Alexander

EXTON, PA — Lungpacer Medical, Inc. has announced pivotal results from the RESCUE-3 trial, published in the American Journal of Respiratory and Critical Care Medicine, showcasing the groundbreaking benefits of …

Lungpacer Medical Publishes Landmark Findings on AeroPace System in Critical Care Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime

May 10, 2025May 8, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced its strategy to secure 7.5 years of U.S. exclusivity for istaroxime, its investigational treatment for cardiogenic shock, if approved by the …

Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime Read More

Teleflex Incorporated
Cardiology

Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transport

April 2, 2025April 1, 2025 - by Timothy Alexander

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced that its AC3 Range™ Intra-Aortic Balloon Pump (IABP) has received FDA 510(k) clearance. Designed for seamless intra-aortic balloon pumping across various modes …

Teleflex Secures FDA Clearance for AC3 Range IABP, Enhancing Cardiac Patient Transport Read More
Lungpacer Medical
Research

Lungpacer Medical Shares Promising Results from STIMULUS Trial

February 20, 2025February 20, 2025 - by Timothy Alexander

EXTON, PA — Lungpacer Medical has unveiled promising results from its groundbreaking STIMULUS trial, a Phase 1 study conducted in collaboration with Toronto General Hospital. Presented at the 2025 Transcatheter Heart …

Lungpacer Medical Shares Promising Results from STIMULUS Trial Read More

Trending News

  • HHS Moves to Speed Alerts for Missing Autistic Americans

  • FDA Clears First Gene Therapy for Rare Glycogen Disorder

  • Radian Adds Payments Executive as Insurance Business Expands

  • Villanova Opens 112-Acre Campus, Adds Housing for 900 Students

  • College Accreditation Overhaul Carries $490 Million Price Tag

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

two man laughing at each other

HHS Moves to Speed Alerts for Missing Autistic Americans

August 24, 2026August 22, 2026

police news

Early-Morning Shooting Leaves Man Wounded in Wilmington

August 24, 2026August 24, 2026

Jian Jian Yu

Fake FBI Threat Nearly Costs Upper Chichester Resident $40,000

August 23, 2026August 22, 2026

Copyright © 2026 MyChesCo.